A Randomized, <scp>Placebo‐Controlled</scp> Phase <scp>III</scp> Extension Trial of the <scp>Long‐Term</scp> Safety and Tolerability of Anifrolumab in Active Systemic Lupus ErythematosusKenneth Kalunian, Hussein Al‐Mossawi, Catharina Lindholm et al.|Arthritis & Rheumatology|2022Cited by 151